| GC32399-10mM(1mLinDMSO) |
|
308831-61-0 |
|
0 |
C36H31F2N5O4S |
|
|
|
| GC32398-10mg |
|
196808-85-2 |
|
0 |
C50H63N13O7 |
|
|
|
| GC32398-5mg |
|
196808-85-2 |
|
0 |
C50H63N13O7 |
|
|
|
| GC32398-1mg |
|
196808-85-2 |
|
0 |
C50H63N13O7 |
|
|
|
| GC32397-50mg |
|
1309370-86-2 |
MSI-1436 lactate (Trodusquemine lactate)
|
0 |
C37H72N4O5S . 7/2C3H6O3 |
|
|
|
| GC32397-10mg |
|
1309370-86-2 |
MSI-1436 lactate (Trodusquemine lactate)
|
0 |
C37H72N4O5S . 7/2C3H6O3 |
|
|
|
| GC32397-5mg |
|
1309370-86-2 |
MSI-1436 lactate (Trodusquemine lactate)
|
0 |
C37H72N4O5S . 7/2C3H6O3 |
|
|
|
| GC32397-1mg |
|
1309370-86-2 |
MSI-1436 lactate (Trodusquemine lactate)
|
0 |
C37H72N4O5S . 7/2C3H6O3 |
|
|
|
| GC32397-10mM(1mLinDMSO) |
|
1309370-86-2 |
MSI-1436 lactate (Trodusquemine lactate)
|
0 |
C37H72N4O5S . 7/2C3H6O3 |
|
|
|
| GC32396-50mg |
|
186139-09-3 |
|
0 |
C37H72N4O5S |
|
|
|
| GC32396-10mg |
|
186139-09-3 |
|
0 |
C37H72N4O5S |
|
|
|
| GC32396-5mg |
|
186139-09-3 |
|
0 |
C37H72N4O5S |
|
|
|
| GC32396-1mg |
|
186139-09-3 |
|
0 |
C37H72N4O5S |
|
|
|
| GC32395-250mg |
|
80-32-0 |
Sulfachloropyridazine (Sulfachlorpyridazine)
|
0 |
C10H9ClN4O2S |
|
|
|
| GC32395-10mM(1mLinDMSO) |
|
80-32-0 |
Sulfachloropyridazine (Sulfachlorpyridazine)
|
0 |
C10H9ClN4O2S |
|
|
|
| GC32394-10mg |
|
5588-20-5 |
Chlordantoin (Clodantoin)
|
0 |
C11H17Cl3N2O2S |
|
|
|
| GC32394-5mg |
|
5588-20-5 |
Chlordantoin (Clodantoin)
|
0 |
C11H17Cl3N2O2S |
|
|
|
| GC32394-1mg |
|
5588-20-5 |
Chlordantoin (Clodantoin)
|
0 |
C11H17Cl3N2O2S |
|
|
|
| GC32393-100mg |
|
967-80-6 |
Sulfaquinoxaline sodium salt
|
0 |
C14H11N4NaO2S |
|
|
|
| GC32393-10mM(1mLinDMSO) |
|
967-80-6 |
Sulfaquinoxaline sodium salt
|
0 |
C14H11N4NaO2S |
|
|
|
